Lexicon Pharmaceuticals (LXRX) Asset Writedowns and Impairment (2010 - 2020)
Lexicon Pharmaceuticals (LXRX) reported Asset Writedowns and Impairment of $1.6 million for Q2 2020, up 105.59% quarter-over-quarter from -$28.6 million in Q4 2019.
Lexicon Pharmaceuticals (LXRX) Asset Writedowns and Impairment (2010 - 2020) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 6 years of Asset Writedowns and Impairment data on file, last reported at $1.6 million in Q2 2020.
- Asset Writedowns and Impairment for Q2 2020 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $1.6 million (changed 0.0% YoY), and the FY2020 annual result was $1.6 million, changed N/A from the prior year.
- Asset Writedowns and Impairment grew to $1.6 million in Q2 2020 per LXRX's latest filing, from -$28.6 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $28.6 million in Q3 2019 and troughed at -$28.6 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.60 Mn |
| Jun 30, 2020 | 1.60 Mn |
| Dec 31, 2019 | -28.64 Mn |
| Dec 31, 2019 | -28.64 Mn |
| Sep 30, 2019 | 28.64 Mn |
| Sep 30, 2019 | 28.64 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Sep 30, 2015 | 2.35 Mn |
| Sep 30, 2015 | 2.35 Mn |
| Dec 31, 2014 | 200,000.00 |
| Dec 31, 2014 | 200,000.00 |
| Sep 30, 2014 | 13.10 Mn |
| Sep 30, 2014 | 13.10 Mn |
| Mar 31, 2014 | 242,000.00 |
| Mar 31, 2014 | 242,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Sep 30, 2011 | -79,000.00 |
| Sep 30, 2011 | -79,000.00 |